A randomized, double-blind, placebo-controlled, crossover trial to assess the effects of zafirlukast (ACCOLATE) 20 mg twice daily when administered with food on exercise-induced bronchoconstriction induced in subjects with asthma.
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available